Cullinan Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Cullinan Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2021 to Q2 2024.
  • Cullinan Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $3.05M, a 40% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.05M -$2.03M -40% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.56M -$1.98M -35.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.07M -$1.88M -31.6% Dec 31, 2023 10-K 2024-03-14
Q3 2023 $4.57M -$1.18M -20.5% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $5.08M +$3.84M +311% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.54M +$4.15M +299% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.95M +$4.41M +287% Dec 31, 2022 10-K 2023-03-09
Q3 2022 $5.76M +$4.07M +241% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.24M -$1.84B -99.9% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.39M -$602K -30.3% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.54M Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.69M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.84B Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $1.99M Mar 31, 2021 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.